Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Rating neurologic impairment in multiple sclerosis
1983 • 14,011 citations
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
1965 • 1,402 citations
The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment
1999 • 911 citations
Interferons α and β as Immune Regulators—A New Look
2001 • 671 citations
Regulatory CD56brightnatural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
2006 • 578 citations
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
2004 • 320 citations
Method for Quantification of Brain, Ventricular, and Subarachnoid CSF Volumes from MR Images
1992 • 257 citations
Treatment of multiple sclerosis with an anti–interleukin‐2 receptor monoclonal antibody
2004 • 167 citations
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results
2007 • 163 citations
Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta
2007 • 139 citations
Clinical scales for multiple sclerosis
1996 • 109 citations
Magnetic resonance imaging measures of brain atrophy in multiple sclerosis
2006 • 109 citations
Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells
2008 • 79 citations
The role of natural killer cells in curbing neuroinflammation
2007 • 47 citations
Human NK Cells Inhibit Cytomegalovirus Replication through a Noncytolytic Mechanism Involving Lymphotoxin-Dependent Induction of IFN-β
2005 • 44 citations
NK and NKT cell dynamics after rituximab therapy for systemic lupus erythematosus and rheumatoid arthritis
2008 • 35 citations
Spotlight on anti-CD25: daclizumab in MS.
2008 • 29 citations
STRUCTURE AND CHEMICAL REACTIONS OF THE COBAMIDE COENZYMES
1964 • 29 citations
Correction
2004 • 16 citations
Cited By (0)
No citing papers found in database